指南与共识血栓与止血

改良凝血因子浓缩物的实验室检测:文献综述与实践推荐

Laboratory assay measurement of modified clotting factor concentrates: a review of the literature and recommendations for practice.
指南 / 共识 · J Thromb Haemost · 2019-02-17

综述指出,新型改良凝血因子浓缩物(CFC)输注后,临床凝血实验室使用一期凝固法检测FVIII/IX水平可能因APTT试剂激活剂类型不同而出现临床相关的低估或高估,并基于文献提出实践推荐。

要点

  • 新型改良CFC输注后,一期凝固法检测FVIII/IX水平可能因APTT试剂激活剂类型而高估或低估。
  • APTT试剂激活剂与CFC的组合决定检测结果偏差方向及临床相关性。
  • 基于文献综述提出实践推荐,供临床医生在临床实践中使用。

核心结论

  • 新型改良凝血因子浓缩物输注后,FVIII/IX水平检测可能因APTT试剂激活剂类型而出现临床相关的高估或低估。
  • 基于文献综述提出实践推荐,供临床医生在临床实践中使用。

研究设计与样本

  • 本文为文献综述,检索范围未在原文中具体报告。

主要发现

  • 近期研究显示,新型FVIII/IX浓缩物输注后检测正确FVIII/IX水平存在显著问题。
  • 问题来源与一期凝固法所用APTT试剂的巨大变异性有关,更具体地与试剂中激活剂类型有关。
  • 根据CFC与APTT激活剂的组合,观察到的结果可能被低估或高估至临床相关程度。

关键数值与推荐

  • 原文未报告具体数值标准或推荐等级。

临床怎么用

  • 基于文献综述提出实践推荐,供临床医生在临床实践中使用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Over the past several years, novel modified clotting factor concentrates (CFCs) have been introduced into practice and are now widely prescribed in the countries where they are licensed. These products allow for less frequent infusions of CFC, thereby providing improved convenience and/or higher trough levels. They have been extensively studied for prophylaxis, episodic treatment of bleeding and for surgical prophylaxis. One issue that has emerged regarding the clinical application of these products revolves around the measurement of infused CFC in the clinical coagulation laboratory. Recent studies have demonstrated significant problems with the measurement of correct FVIII/IX levels following infusion of novel CF VIII/IX concentrates. The source of this problem appears to be related to the tremendous variability of the APTT reagents that are used in the one-stage clotting assay, the most commonly used assay for determining factor levels. More specifically, the issue is related to the type of activator used in the reagents. Depending on the combination of the CFC and the APTT activator, the observed results may be either under- or overestimated to degrees that would be clinically relevant. Recommendations based on a review of published information regarding the potential for incorrect measurements of factor VIII/IX levels following infusion of recently developed, novel factor VIII/IX CFCs are presented for the clinician to use in clinical practice.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Young GA, Perry DJ. Laboratory assay measurement of modified clotting factor concentrates: a review of the literature and recommendations for practice. J Thromb Haemost. 2019. PMID: 30667575. doi:10.1111/jth.14394

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。